Skip to main content
main-content

EASD 57th Annual Meeting 2021

27 SEPTEMBER – 1 OCTOBER 2021
Top story

Intra-organ fat reduction parallels type 2 diabetes remission in lean people

Intra-organ fat reduction parallels type 2 diabetes remission in lean people

Outwardly lean people who have type 2 diabetes have increased intra-organ fat, reductions in which occur in line with weight loss-induced diabetes remission, say researchers.

Top story

SUSTAIN 10 analysis supports additive benefits of GLP-1 receptor agonists, SGLT2 inhibitors

SUSTAIN 10 analysis supports additive benefits of GLP-1 receptor agonists, SGLT2 inhibitors

A post-hoc analysis of SUSTAIN 10 indicates that people with type 2 diabetes stand to gain from GLP-1 receptor agonist use even if they are already using an SGLT2 inhibitor.

EASD 2021 interviews

08-10-2021 | EASD 2021 | Conference coverage | Video

The ADA/EASD type 1 diabetes consensus: Comprehensive and up to date

Parth Narendran gives his highlights of the ADA/EASD type 1 diabetes management consensus report, and explains how it can support clinicians to deliver improved services for their patients.

01-10-2021 | EASD 2021 | Conference coverage | Video

How will the TriMaster results impact patient-centered care?

Pinar Topsever comments on the TriMaster study of a stratified medicine approach to second- and third-line treatment for type 2 diabetes, and discusses what the results mean for primary care practice.

01-10-2021 | EASD 2021 | Conference coverage | Video

Management of type 1 diabetes: ADA/EASD consensus report

Anne Peters talks about the goals of the ADA/EASD type 1 diabetes management consensus report, the issues to urgently address, and the joys of being part of a trans-Atlantic collaboration.

More EASD 2021 research news

05-10-2021 | EASD 2021 | Conference coverage | News

Omnipod DASH benefits confirmed in real-world study

04-10-2021 | EASD 2021 | Conference coverage | News

SoliMix trial supports iGlarLixi for type 2 diabetes


Medicine Matters conference coverage is brought to you in partnership with medwireNews


Image Credits